PROCEPT BioRobotics (PRCT) Depreciation & Amortization (CF) (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.7 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $1.7 million, up 17.63% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.6 million (up 20.36% YoY), and the FY2025 annual result was $6.4 million, up 22.09% from the prior year.
• Depreciation & Amortization (CF) climbed to $1.7 million in Q1 2026 per PRCT's latest filing, from $1.7 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $1.7 million in Q1 2026 and troughed at $642000.0 in Q2 2023.
• A 5-year average of $1.2 million and a median of $1.3 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) fell 17.16% in 2022, then soared 98.79% in 2023.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $663000.0 in 2022, then soared by 98.79% to $1.3 million in 2023, then gained by 10.24% to $1.5 million in 2024, then increased by 17.62% to $1.7 million in 2025, then gained by 1.52% to $1.7 million in 2026.
• Business Quant data shows PRCT's Depreciation & Amortization (CF) at $1.7 million in Q1 2026, $1.7 million in Q4 2025, and $1.6 million in Q3 2025.